Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IGSF9 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | PARP11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | RNF183 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | GSTO2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | RP4-613B23.5 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | COQ2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | VWCE | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | ARHGAP45 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
mRNA | ARFGEF3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | ZMAT4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |